< Back to previous page
Researcher
Johan Maertens
- Disciplines:Biochemistry and metabolism, Microbiology, Systems biology, Laboratory medicine, Medical biochemistry and metabolism
Affiliations
- Laboratory of Clinical Microbiology (Division)
Member
From1 Oct 2014 → Today - Department of Microbiology, Immunology and Transplantation (Department)
Member
From1 Oct 2013 → 30 Sep 2014 - Woman and Child (Division)
Member
From1 Apr 2013 → 30 Sep 2013
Projects
1 - 10 of 11
- Insights in febrile neutropenia (SAFE study) and clinical and translational insights in (invasive) mold infections and mycology, with the focus on Hematologic patients.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimization and validation of collateral sensitivity based alternative treatment strategies for multidrug resistant CandidemiaFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- SAFE study: a randomized non-inferiority trialFrom1 Oct 2022 → TodayFunding: Foundations, funds and other with scientific goal
- Improving prevention and treatment strategies concerning opportunistic infections in immunocompromised hematologic patientsFrom14 Sep 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Clonal evolution and biology of co-operative oncogenic events in acute lymphoblastic leukemia.From1 Oct 2018 → 30 Sep 2023Funding: Fund Recuperation Fiscal Exemption
- Fast diagnosis of opportunistic respiratory infections trough exhaled breath analysisFrom1 Oct 2017 → 30 Sep 2020Funding: FWO Applied Biomedical Research (TBM)
- Triazole-resistance in Aspergillus fumigatus: evolving epidemiology and influence on disease progression.From15 Mar 2017 → 2 Dec 2021Funding: BOF - doctoral mandates, BOF - Doctoral projects
- Faster to the fungus: rapid diagnostic and prognostic tests for invasive fungal diseasesFrom1 Aug 2016 → 9 Oct 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Rethinking 'Care after Cure' in allogeneic hematopoietic stem cell transplantation using e-Health and patient reported outcomesFrom1 Sep 2015 → 14 Nov 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Assessment of the impact of emerging azole resistance mechanisms on treatment response of invasive pulmonary aspergillosis using non-invasive imaging in experimental Aspergillus infection models.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
Publications
441 - 450 of 536
- Forty-one recent cases of invasive zygomycosis from a global clinical registry
Authors: Johan Maertens
Pages: 296 - 302 - Autologous Blood Stem Cell Transplantation Results In Better Relapse-Free Survival Than Consolidation Chemotherapy: Results of a HOVON/SAKK Phase III Trial In 519 AML Patients In First Complete Remission
Authors: Edo Vellenga, Wim van Putten, Gert J Ossenkoppele, Martin Fey, Jurgen Kuball, Matthias Theobald, Jan J Cornelissen, Peter Huijgens, Johan Maertens, Alois Gratwohl, et al.
Pages: 166 - 166 - Trends in outcome of transplantation in patients with secondary acute myeloid leukemia: an analysis from the Acute Leukemia Working Party (ALWP) of the EBMT
Authors: Johan Maertens
Pages: 1788 - 1796 - Cladophialophora bantiana osteomyelitis in a renal transplant patient
Authors: Stefanie Desmet, Inge Derdelinckx, Johan Maertens, Raf Sciot, Philippe Demaerel, Bert Bammens
Pages: 17 - 20 - Rapid and direct quantification of viable Candida species in whole blood by use of immunomagnetic separation and solid-phase cytometry
Authors: Wouter Meersseman, Johan Maertens
Pages: 1126 - 1131 - Azole resistance in Aspergillus: an emerging problem?
Authors: Johan Maertens
Pages: 322 - 327 - Outcome of COVID-19 in allogeneic stem cell transplant recipients: Results from the EPICOVIDEHA registry
Authors: Johan Maertens
- Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines
Authors: M Mikulska, D Averbuch, F Tissot, C Cordonnier, M Akova, T Calandra, M Ceppi, P Bruzzi, C Viscoli, M Aljurf, et al.
Pages: 20 - 37 - Validation of the Transplant Conditioning Intensity (TCI) Score for Allogeneic Hematopoietic Cell Transplantation
Authors: Johan Maertens
Pages: 2389 - 2391 - Allogeneic stem cell transplantation in patients with CML-CP in the era of third generation tyrosine kinase inhibitors: a study by the CMWP of the EBMT
Authors: Yves Chalandon, Giulia Sbianchi, Jennifer Hoek, Jane Apperley, Maija Itala-Remes, Miroslaw Markiewicz, Jenny Byrne, Henrik Sengeloev, Naeem Chaudri, Ram Malladi, et al.
Pages: 45 - 46